Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer.
Authors: Matsumoto K; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Yamamoto Y; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan. Electronic address: takayuki.s12@hotmail.co.jp., Kuge T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan., Miyazaki A; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Komuta K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tsukaguchi A; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Tamiya A; Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Mihashi Y; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan., Uchida J; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan., Mori M; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan., Yamauchi K; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan., Suzuki H; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan., Kinehara Y; Department of Respiratory Medicine and Clinical Immunology, Nippon Life Hospital, Osaka, Japan., Moritomo K; Department of Respiratory Medicine, Osaka Keisatsu Hospital, Osaka, Japan., Shoshihara N; Department of Respiratory Medicine, Osaka Keisatsu Hospital, Osaka, Japan., Machiyama H; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Kanaoka K; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Tobita S; Department of Respiratory Medicine, Osaka General Medical Center, Osaka, Japan., Ueno K; Department of Respiratory Medicine, Osaka General Medical Center, Osaka, Japan., Niki T; Department of Respiratory Medicine, Nishinomiya Municipal Central Hospital, Hyogo, Japan., Tetsumoto S; Department of Respiratory Medicine and Clinical Immunology, Suita Municipal Hospital, Osaka, Japan., Nishikawa Y; Department of Respiratory Medicine, Toyonaka Municipal Hospital, Osaka, Japan., Morimura O; Department of Respiratory Medicine, Toyonaka Municipal Hospital, Osaka, Japan., Kato S; Department of Respiratory Medicine, Ikeda City Hospital, Osaka, Japan., Yoneda M; Department of Respiratory Medicine, Ikeda City Hospital, Osaka, Japan., Azuma K; Department of Respiratory Medicine, NHO Osaka National Hospital, Osaka, Japan., Osa A; Department of Respiratory Medicine, Kinki Central Hospital, Hyogo, Japan., Minami T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Hyogo, Japan., Nagatomo I; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Takeda Y; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan., Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan; Department of Immunopathology, World Premier International (WPI), Immunology Frontier Research Center (iFReC), the University of Osaka, Osaka, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), the University of Osaka, Osaka, Japan; Center for Infectious Diseases for Education and Research (CiDER), the University of Osaka, Suita, Osaka, Japan; Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), the University of Osaka, Osaka, Japan; Center for Advanced Modalities and DDS (CAMaD), the University of Osaka, Osaka, Japan.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 21; Vol. 244, pp. 116902. Date of Electronic Publication: 2026 Jun 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2026.116902